cancer vaccine

News

ASCO: Moderna may file melanoma vaccine on phase 2b data

New data from a phase 2b trial of Moderna and MSD’s neoantigen melanoma vaccine may be strong enough to consider filing for accelerated approval before a phase 3 programme

News

Dr Elias Sayour, Chong Zhao and Arnav Barpujari discuss the mRNA cancer vaccine developed at the University of Florida

RNA glioblastoma vaccine shows promise in first human trial

A personalised vaccine for the aggressive and fatal brain cancer glioblastoma has shown encouraging signs of efficacy in its first human trial.

News

MSD, Moderna start phase 3 trial of mRNA cancer jab

MSD & Co and Moderna have advanced a combination of an mRNA-based cancer vaccine and checkpoint inhibitor Keytruda into a phase 3 trial in skin cancer melanoma, althou

News

ASCO: Moderna, Merck melanoma vaccine set for phase 3

Moderna’s move into personalised cancer therapy continues to proceed at a rapid pace, with Merck & Co-partnered melanoma vaccine mRNA-4157 heading for a pivotal phase

News

Merck, Moderna cue up phase 3 trials for mRNA cancer shot

Moderna and partner Merck & Co have fleshed out the data from their clinical trial of personalised mRNA vaccine for melanoma, saying the results support the start of a

News

Merck and Moderna's mRNA cancer vaccine aces its first effic...

The mRNA technology that was deployed so effectively in vaccines against COVID-19 has now been found to offer similar promise against cancer, according to Merck & Co and Moderna.

ASCO: Moderna may file melanoma vaccine on phase 2b data

RNA glioblastoma vaccine shows promise in first human trial

MSD, Moderna start phase 3 trial of mRNA cancer jab

ASCO: Moderna, Merck melanoma vaccine set for phase 3

Merck, Moderna cue up phase 3 trials for mRNA cancer shot

Merck and Moderna's mRNA cancer vaccine aces its first effic...

Jasper and Kira merge to build immune-focused biotech

Discover a new era of healthcare panel engagement: Grounded ...

cancer vaccine

Editor's Picks